Dr RYMZHANOVA Raouchan

Impact of tomosynthesis on the evolution of the cancer detection rate in the French National Breast Cancer Screening Program.

Balamou C, Koïvogui A, Zysman K, Rodrigue CM, Rymzhanova R

Public Health. 2022 07 20;210:65-73

[Second Reading in Breast cancer screening program: State of knowledge and future].

Ceugnart L, Doutriaux-Dumoulin I, Heid P, Orabona J, Deghaye M, Dufour M, Tardivon A, Potocki J, Gautier CP, Brault I, Rymzhanova R, Barraux-Krabe M, Seradour B

Bull Cancer. 2022 05 19;:

Breast cancer incidence by age at discovery of mammographic abnormality in women participating in French organized screening campaigns.

Balamou C, Koïvogui A, Rymzhanova R, Cornelis S, Rodrigue-Moulinie C, Sellier N

Public Health. 2021 Dec 21;202:121-130

Colorectal cancer fecal screening test completion after age 74, sources and outcomes in French program.

Koïvogui A, Balamou C, Rymzhanova R, Letrung T, Hadad HA, Brixi Z, Cornelis S, Delattre-Massy H, Aparicio T, Benamouzig R

World J Gastrointest Oncol. 2019 Sep 15;11(9):729-740

Gautier CP, Tournoux-Facon C, Rymzhanova R

Sante Publique. 2016 Oct 19;28(4):481-486